Kamada Ltd.
(TEL Aviv Stock Exchange : KMDA)

( )
KMDA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -6.02%384.210.0%$5285.71m
BNTXBioNTech SE -9.96%276.520.0%$899.27m
NVAXNovavax, Inc. -11.34%204.8379.4%$857.11m
SNSSSunesis Pharmaceuticals, Inc. -5.26%7.930.7%$554.34m
AMGNAmgen, Inc. -0.39%212.271.4%$540.36m
GILDGilead Sciences, Inc. -0.63%69.971.0%$446.95m
REGNRegeneron Pharmaceuticals, Inc. -2.27%605.002.7%$428.21m
ILMNIllumina, Inc. -3.61%410.203.5%$346.87m
BIIBBiogen, Inc. -0.67%284.711.7%$303.41m
VRTXVertex Pharmaceuticals, Inc. -0.99%181.601.9%$247.39m
ISEEIVERIC bio, Inc. -10.97%15.580.0%$187.66m
LIFEaTyr Pharma, Inc. -1.41%9.762.1%$149.96m
BGNEBeiGene Ltd. -3.55%363.801.3%$141.01m
TECHBio-Techne Corp. -4.42%488.874.5%$131.91m
KDMNKadmon Holdings, Inc. -0.45%8.800.8%$129.86m

Company Profile

Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following segments: Proprietary Products and Distribution. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.